February 16, 2025 - 17:02
A public health alert has been announced regarding meat and poultry pasties produced by a restaurant based in Michigan. The alert stems from the discovery of an undeclared allergen—specifically, egg—on the product's packaging. Consumers who are allergic to eggs are at risk if they consume these pasties, as the allergen was not listed, potentially leading to serious health complications.
The affected pasties were distributed to various locations and may still be present on store shelves. Authorities are urging anyone who has purchased these products to check their packaging carefully. If the pasties are found to contain the undeclared allergen, individuals with egg allergies should avoid consuming them and return the product to the place of purchase for a refund.
Public health officials emphasize the importance of proper labeling to ensure consumer safety, particularly for those with food allergies. This incident serves as a reminder for both manufacturers and consumers to remain vigilant regarding food safety and allergen awareness.
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...